We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
Cap. Flow
-$5.86B
Cap. Flow %
-1.71%
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.03B
2
VLO icon
Valero Energy
VLO
+$273M
3
PGR icon
Progressive
PGR
+$259M
4
AMD icon
Advanced Micro Devices
AMD
+$256M
5
ORLY icon
O'Reilly Automotive
ORLY
+$232M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Financials 11.71%
3 Healthcare 11.09%
4 Consumer Discretionary 10.64%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHC icon
1801
Graham Holdings Company
GHC
$4.94B
$6.32M ﹤0.01%
9,031
+50
+0.6% +$36.5K
AUR icon
1802
Aurora
AUR
$13.6B
$6.31M ﹤0.01%
2,279,442
+803,032
+54% +$2.22M
UFPT icon
1803
UFP Technologies
UFPT
$2.46B
$6.31M ﹤0.01%
23,928
-13,780
-37% -$3.4M
PNTG icon
1804
Pennant Group
PNTG
$1.37B
$6.31M ﹤0.01%
271,912
-84,158
-24% -$1.84M
CC icon
1805
Chemours
CC
$2.22B
$6.3M ﹤0.01%
279,208
-42,807
-13% -$1.12M
PAR icon
1806
PAR Technology
PAR
$737M
$6.3M ﹤0.01%
133,759
+6,628
+5% +$293K
DNB
1807
DELISTED
Dun & Bradstreet
DNB
$6.29M ﹤0.01%
679,360
-1,976
-0.3% -$19K
KGS icon
1808
Kodiak Gas Services
KGS
$6.08B
$6.27M ﹤0.01%
230,042
+138,244
+151% +$3.75M
WERN icon
1809
Werner Enterprises
WERN
$2.23B
$6.24M ﹤0.01%
174,235
+3,394
+2% +$124K
CSTL icon
1810
Castle Biosciences
CSTL
$1B
$6.24M ﹤0.01%
286,511
+96,883
+51% +$2.16M
HRMY icon
1811
Harmony Biosciences
HRMY
$2.27B
$6.16M ﹤0.01%
204,158
-199,211
-49% -$5.99M
SSTK icon
1812
Shutterstock
SSTK
$218M
$6.16M ﹤0.01%
159,141
+93,980
+144% +$3.82M
NEO icon
1813
NeoGenomics
NEO
$2.14B
$6.14M ﹤0.01%
442,750
-177,521
-29% -$2.52M
RYTM icon
1814
Rhythm Pharmaceuticals
RYTM
$7.94B
$6.12M ﹤0.01%
149,119
+6,384
+4% +$255K
MRCY icon
1815
Mercury Systems
MRCY
$6.58B
$6.11M ﹤0.01%
226,429
-53,730
-19% -$1.57M
GOGL
1816
DELISTED
Golden Ocean Group
GOGL
$6.1M ﹤0.01%
441,530
+2,144
+0.5% +$29.6K
CWK icon
1817
Cushman & Wakefield Ltd
CWK
$3.13B
$6.08M ﹤0.01%
584,402
+54,864
+10% +$567K
TVTX icon
1818
Travere Therapeutics
TVTX
$5.83B
$6.06M ﹤0.01%
737,638
+6,260
+0.9% +$42.2K
RNG icon
1819
RingCentral
RNG
$5.42B
$6.06M ﹤0.01%
214,975
+907
+0.4% +$29.2K
GBX icon
1820
The Greenbrier Companies
GBX
$1.43B
$6.06M ﹤0.01%
122,344
+3,772
+3% +$196K
PAX icon
1821
Patria Investments
PAX
$1.82B
$6.05M ﹤0.01%
501,729
+12,720
+3% +$168K
GDOT icon
1822
Green Dot
GDOT
$741M
$6.04M ﹤0.01%
639,193
-37,493
-6% -$349K
HSTM icon
1823
HealthStream
HSTM
$862M
$6.03M ﹤0.01%
216,304
+2,126
+1% +$56.7K
PAG icon
1824
Penske Automotive Group
PAG
$14.2B
$6.03M ﹤0.01%
40,485
-13,481
-25% -$2.05M
PLAY icon
1825
Dave & Buster's
PLAY
$345M
$6.03M ﹤0.01%
151,415
-30,506
-17% -$1.58M

Similar funds

Nuveen's Q2 2024 Portfolio in Review

As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
  • Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
  • Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
  • Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
  • Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
  • Nuveen opened 211 new positions and closed 159 in Q2 2024.
  • Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.